Pericoital UPA + Meloxicam
Description: Dosing of ulipristal acetate and meloxicam given at a peak fertility time point. Ulipristal is effective during the follicular time period and the theoretical mechanism of meloxicam to disruption of cumulus-oocyte expansion in a late step of ovulation.
Product Details
Regimen:
Dose: ulipristal acetate 30mg plus meloxicam 15mg
Active Pharmaceutical Ingredient (API):
Status Details
Began discovery in: 2017
Status Details: - Exploratory prospective study initiated in January 2018 investigating if addition of a COX-2 inhibitor can increase efficacy of ulipristal in disrupting ovulation at peak fertility. Expected study completion in July 2018.
- Exploratory prospective study initiated in January 2018 investigating if addition of a COX-2 inhibitor can increase efficacy of ulipristal in disrupting ovulation at peak fertility. Expected study completion in July 2018.
Additional Information
References: ClinicalTrials.gov Identifier: NCT03354117
ClinicalTrials.gov Identifier: NCT03354117